Clinical Trials Logo
  1. Home
  2. Transplant
  3. NCT03847285

Immune Function as Predictor of Infectious Complications and Clinical Outcome in Patients Undergoing Solid Organ Transplantation — Immune-Mo  

Transplant Clinical Trial

Official title:
Immune Function as Predictor of Infectious Complications and Clinical Outcome in Patients Undergoing Solid Organ Transplantation: A Prospective Non-interventional Observational Trial

Clinical Trial Summary

At Rigshospitalet, Denmark, we will examine the immune function of solid organ transplant recipients before and at several timepoints after transplantation as well as the clinical outcome, especially the risk of infections complications and graft rejections. The immune function will be assessed with a complete immunological profiling consisting of immune phenotype (flow cytometry), immune function (TruCulture®) and circulating biomarkers. The study aims to generate prediction models of patients at excess risk of poor clinical outcome, with the ultimate intent to propose personalized immunosuppressive regimes to be tested in future randomized clinical trials.

Clinical Trial Description

Background: Solid organ transplantation (SOT) is an increasingly used life-saving treatment for end-stage organ failure. Organ rejection and infections are the main complication to SOT and the balance of immunosuppression is of major importance to prevent these complications. However, to date the only mode to monitor treatment is by assessing drug concentrations, which has low correlation with the clinical outcome and does not represent the net state of immunosuppression. Methods: Prospectively the investigators plan to enroll 600 adult patients on the waiting list for SOT or with a planned transplantation at Rigshospitalet, Denmark. Prior to transplantation and on different time points up to two years post-transplantation we will perform a complete immunological profile. This profile will consist of classical descriptive immune phenotyping (flowcytometry), circulating biomarkers and the functional assay TruCulture®. In TruCulture® whole blood is stimulated with stimulants imitating bacterial, viral and fungal infections, where after a panel of selected cytokines is quantified. Clinical data from electronic health records will be obtained retrospectively from the PERSIMUNE data repository. These data are generated as part of routine care and include vital signs, biochemistry-, microbiological-, pathological-results as well as data about medication, demographics, diagnoses, hospital contacts, surgical procedures and mortality. Discussion: This will be the first large scale study to determine several aspects of immune function and perform a complete immunological profiling in SOT recipients. It is expected that this new knowledge will provide information to generate prediction models identifying patients at increased risk of infection and/or rejection. If the study is successful, the investigators will subsequently use the generated prediction models to propose personalized immunosuppressive regimens to be tested in future randomized controlled trials. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03847285
Study type Observational
Source Rigshospitalet, Denmark
Contact
Status Active, not recruiting
Phase
Start date April 1, 2018
Completion date January 31, 2026
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05047068 - OCS Heart Perfusion Post-Approval Registry
Completed NCT03455062 - Fertility Study of Women Who Received Organ Transplantation N/A
Terminated NCT05033548 - Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
Recruiting NCT04182607 - Donor Outcomes Following Hand-Assisted And Robotic Living Donor Nephrectomy: A Retrospective Review
Completed NCT01022905 - Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients Phase 4
Completed NCT00436384 - Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients Phase 4
Active, not recruiting NCT03691220 - Improving Medication Adherence in Adolescents Who Had a Liver Transplant N/A
Completed NCT00571818 - The Prospective Evaluation of Pancreatic Function in Pancreas Transplant Recipients N/A
Terminated NCT00884039 - Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients N/A
Completed NCT00677677 - Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients Phase 3
Completed NCT03860818 - Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention N/A
Recruiting NCT04626167 - Concomitant Renal and Urinary Bladder Allograft Transplantation Early Phase 1
Completed NCT01389804 - Parents of Pediatric Solid Organ Transplant Recipients: Transition to Home and Chronic Illness Care N/A
Recruiting NCT04390724 - Optimizing Y90 Therapy for Radiation Lobectomy
Not yet recruiting NCT04690036 - PD-1 Antibody for Reactive EBV After BMT Early Phase 1
Active, not recruiting NCT00152802 - Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine Phase 4
Not yet recruiting NCT05951231 - Liver Transplantation After ex Vivo Liver Perfusion N/A
Completed NCT00242099 - Clinical Utility of Monitoring for Human Herpesvirus-6 (HHV-6) and Human Herpesvirus-7 (HHV-7) After Liver Transplant Phase 4
Recruiting NCT05717842 - Simultaneous Prospective Kidney Transplant Assessment in Combined Liver Kidney Candidates
Active, not recruiting NCT05655546 - ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals N/A